Celebrating the 2024 PharmaTimes MSEA and NIEA awards
The awards celebrated both medical affairs and nursing professionals in the industry
Read More
Author: Jen Brogan
Innovate UK grants £4m to four companies to evaluate biomarkers for dementia
The progressive neurodegenerative disease affects more than 55 million people globally
Read More
UK Researchers developing new tetanus test to identify global immunity gaps
The serious, rare condition is responsible for up to 7% of all neonatal deaths globally
Read More
Researchers awarded £1.5m for national dementia inequalities network
The ESRC EquaDem Network Plus aims to improve disparities in diagnosis and care
Read More
New policy review reveals ten cancer challenges facing new UK government
Macmillan Cancer Support estimates that cancer affects over three million people in the UK
Read More- Oxford BioTherapeutics signs collaboration with Bristol Myers Squibb
- Kainova expands DT 7012 trial into Europe
- Amgen reports positive phase 3 results for subcutaneous TEPEZZA in thyroid eye disease
- CatalYm begins phase 2b trial of visugromab in second-line liver cancer treatment
- FDA approves new high dose Spinraza regimen for SMA
